Schrodinger, Inc. stock is up 45% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs. 0% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
12 Oct 14:34 | 17 Jan, 2025 | 35.00 | 71 | ||
13 Oct 19:47 | 16 Jan, 2026 | 20.00 | 6 | ||
16 Oct 13:30 | 17 Jan, 2025 | 30.00 | 104 | ||
02 Nov 16:03 | 19 Jan, 2024 | 35.00 | 457 | ||
02 Nov 16:38 | 17 Nov, 2023 | 25.00 | 475 | ||
03 Nov 16:53 | 19 Jan, 2024 | 40.00 | 915 | ||
14 Nov 17:43 | 19 Jan, 2024 | 45.00 | 494 | ||
15 Nov 18:42 | 21 Jun, 2024 | 45.00 | 7 | ||
20 Nov 19:59 | 15 Dec, 2023 | 35.00 | 501 | ||
24 Nov 17:18 | 21 Jun, 2024 | 35.00 | 139 |
Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The Software segment is focused on selling its software for drug discovery in the life sciences industry. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.